Macquarie Group’s Instil Bio TIL Stock Holding History

Macquarie Group’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,000	Closed	-$893K	–	1446
2025 Q3	$893K	Hold	50,000	–	–	﹤0.01%	1339
2025 Q2	$1.04M	Buy	+50,000	New	+$1.05M	﹤0.01%	1367

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group's TIL Position: Q4 2025 in Review

Macquarie Group sold out of Instil Bio (TIL) in Q4 2025, closing a stake of 50,000 shares — an estimated $893K sold.

Macquarie Group first reported a position in TIL in Q2 2025 and held it in 2 quarters. The position peaked at $1.04M in Q2 2025. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

Macquarie Group reported no remaining Instil Bio position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 50,000 Instil Bio shares in Q4 2025, an estimated $893K.
Macquarie Group first reported a position in Instil Bio in Q2 2025 and held it in 2 quarters.
Macquarie Group's Instil Bio position peaked at $1.04M in Q2 2025.
29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.